[email protected]

Category: Pharma Audits

Why Some Companies Fail Inspections on Training Records

Pharma Audits

Why Some Companies Fail Inspections on Training Records, Not Case Quality

August 27, 2026 No Comments

Why Smaller Pharma Companies Get Hit Harder

Pharma Audits

Why Smaller Pharma Companies Get Hit Harder by GMP Findings Than They

August 20, 2026 No Comments

Critical MHRA Finding

Pharma Audits

What Happens After You Receive a Critical MHRA Finding

August 11, 2026 No Comments

Pharma Audits

Annex 1 Sterile Manufacturing: Frequently Missed Compliance Requirements

August 4, 2026 No Comments

GMP Consultant vs Quality Manager

Pharma Audits

GMP Consultant vs Full-Time Quality Manager: Which Is Better for SMEs?

July 28, 2026 No Comments

Next MHRA Inspection

Pharma Audits

Your CMO Has a GMP Certificate. Here’s Why That’s Not Enough for Your Next MHRA Inspection

July 16, 2026 No Comments

FDA Draft

Pharma Audits

FDA Draft Guidance on Responding to Form 483 Observations: A Practical Guide for CGMP Sites

June 18, 2026 No Comments

GDP 2026

Pharma Audits

GDP 2026: Understanding MHRA, DSCSA, and Global Traceability Requirements

June 9, 2026 No Comments

PSMF Maintenance Checklist

Pharma Audits

PSMF Maintenance Checklist: What Needs Updating After a Licence Variation, Product Transfer or MAH Change

June 2, 2026 No Comments

EMA, FDA and MHRA GMP Annex Revisions

Pharma Audits

EMA, FDA and MHRA GMP Annex Revisions 2026- 2028: What Every Pharma QA Team Must Prepare For

May 26, 2026 No Comments

Let’s build a GxP-compliant future together.

Have a project in mind?

Partner with us to elevate your quality systems, ensure compliance, and drive meaningful business transformation.

Built with passion and purpose. Helping you grow smarter, not harder.

QUICK LINKS

CONTACT US

[email protected]

Newsletter Signup

Subscribe to our newsletter for the latest insights

Copyright © 2026 Quality Vigilance Ltd | All Rights Reserved || Powered by Prabisha Consulting